Luping Lin
First Affiliated Hospital of Xiamen University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Epigenetics and DNA Methylation, Cancer, Hypoxia, and Metabolism, PI3K/AKT/mTOR signaling in cancer, Cancer Genomics and Diagnostics
Most-Cited Works
- → Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer(2012)1,207 cited
- → The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies(2015)552 cited
- → RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer(2015)276 cited
- → NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer(2015)200 cited
- → Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer(2014)107 cited
- → Antiviral activity of lycorine against Zika virus in vivo and in vitro(2020)100 cited
- → Mechanisms of Resistance to Epidermal Growth Factor Receptor Inhibitors and Novel Therapeutic Strategies to Overcome Resistance in NSCLC Patients(2012)81 cited
- → DENV NS1 and MMP-9 cooperate to induce vascular leakage by altering endothelial cell adhesion and tight junction(2021)81 cited
- → Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF -mutant lung cancer(2016)77 cited
- → Resuscitating Cancer Immunosurveillance: Selective Stimulation of DLL1-Notch Signaling in T cells Rescues T-cell Function and Inhibits Tumor Growth(2011)75 cited